Rui Cui
State Key Laboratory Of Microbial Diversity And Innovative Utilization
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
Structural and functional characterization of dihydrodiol dehydrogenase PahB recognizing high-molecular-weight PAH substrates.
Journal: Applied and environmental microbiology
Published: June 24, 2026
Rapid Screening of Bacterial Chemoeffectors of Pseudomonas parafulva Using a CheA ATPase Activity-Based Assay.
Journal: Environmental microbiology
Published: April 12, 2026
Correction: Predictors and responses to varying durations of BTK inhibitor bridging therapy before anti-CD19 CAR-T cell therapy in patients with relapsed/refractory DLBCL.
Journal: Frontiers in immunology
Published: February 20, 2026
Long-term follow-up results of anti-BCMA CAR-T cell therapy combined with autologous hematopoietic stem cell transplantation in relapsed/refractory multiple myeloma with extramedullary disease.
Journal: Journal of translational medicine
Published: January 12, 2026
Correlation between the expression of soluble BCMA and short-term/long-term curative effect and survival outcomes of anti-BCMA CAR-T cell therapy in relapsed/refractory multiple myeloma.
Journal: Cell transplantation
Published: September 20, 2025
Pretreatment With BTK Inhibitors Improved the Sensitivity of DLBCL Cells to CAR-T Cells in a Coculture System by Downregulating the Polarisation of M2 Macrophages.
Journal: Journal of cellular and molecular medicine
Published: September 03, 2025
Predictors and responses to varying durations of BTK inhibitor bridging therapy before anti-CD19 CAR-T cell therapy in patients with relapsed/refractory DLBCL.
Journal: Frontiers in immunology
Published: July 27, 2025
Separation and Identification of a Novel Antioxidant and Calcium-Binding Peptide Derived from Phosvitin Hydrolysates: In Vitro and In Silico Prediction.
Journal: Journal of agricultural and food chemistry
Published: June 06, 2025
De novo AML spontaneously achieved PR after COVID-19 infection, and CR after reduced dose of azacytidine combined with venetoclax: A case report and literature review.
Journal: Medicine
Published: April 28, 2025
Last Updated: 09/26/2026